Biosante Pharmaceuticals Inc (NASDAQ:BPAX)

CAPS Rating: 2 out of 5

A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.

Recs

0
Player Avatar trhdawg (21.92) Submitted: 4/13/2011 4:06:12 PM : Outperform Start Price: $2.02 BPAX Score: -75.41

Speculation.

Report this Post Reply

Featured Broker Partners


Advertisement